PLUS THERAPEUTICS INC (PSTV:NASDAQ)
$6.43 -0.21 (-3.1627%)
Analysed PLUS THERAPEUTICS INC (PSTV:NASDAQ) News Sources
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
28-04-2026
yahoo.com
Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic
07-05-2026
yahoo.com
OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates
08-05-2026
yahoo.com
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases
08-05-2026
yahoo.com
Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates
11-05-2026
yahoo.com
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
14-05-2026
247wallst.com
Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
15-05-2026
yahoo.com
Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates
15-05-2026
yahoo.com
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
19-05-2026
yahoo.com
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
26-05-2026
yahoo.com
What is the current price of PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The current price of PLUS THERAPEUTICS INC (PSTV:NASDAQ) is $6.43.
PLUS THERAPEUTICS INC (PSTV:NASDAQ) absolute price change since previous trading day?
The absolute price change of PLUS THERAPEUTICS INC (PSTV:NASDAQ) since the previous trading day is $-0.21.
PLUS THERAPEUTICS INC (PSTV:NASDAQ) percentage price change since previous trading day?
The percentage price change of PLUS THERAPEUTICS INC (PSTV:NASDAQ) since the previous trading day is -3.1627%.
What is the most recent average sentiment score for PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The most recent average sentiment score for PLUS THERAPEUTICS INC (PSTV:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The most recent sentiment for PLUS THERAPEUTICS INC (PSTV:NASDAQ) is .
SEC-8K** Filing Available For PLUS THERAPEUTICS INC (PSTV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.